Pain News and Research

Latest Pain News and Research

Results from second Phase III placebo controlled study of EXPAREL announced

Pacira Pharmaceuticals, Inc., announced today that its second Phase III placebo controlled study of EXPAREL(TM) (DepoBupivacaine) met its primary endpoint.

2 Dec 2009

J&JPRD submits an NDA for tapentadol ER tablets

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.

2 Dec 2009

Surgeons remove rectal mass using innovative surgical approach

Performing surgical operations without leaving scars has ceased to be a chimera and has become a reality. This is demonstrated by the recent surgical advances made using NOTES (Natural Orifice Transluminal Endoscopy Surgery), an innovative surgical approach that allows surgical access using the body's natural orifices.

2 Dec 2009

Pulmonary embolism can be diagnosed by combining SPECT and low-dose CT, shows research

When it comes to diagnosing pulmonary embolism-a sudden blockage in the lung artery that could be deadly if not treated-which technique is the most effective?

2 Dec 2009

OptiNose announces study results of intranasal device for treating chronic rhinosinusitis with nasal polyps

OptiNose is pleased to announce the publication of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the topical treatment of chronic rhinosinusitis with nasal polyps in Rhinology, the official journal of the International and European Rhinologic Societies.

2 Dec 2009

Survey and existing research reveal differences in pain management between genders

For many Canadians, December is the start of the holiday season and a time of joy and celebration, but for some, it can also be a time of increased aches and pains. Whether it's a backache from shoveling away the first snowfall, hanging holiday lights or a headache from the stress of holiday shopping, December brings a new set of aches and pains.

2 Dec 2009

Percutaneous disc decompression keeps patients pain-free up to two years later, shows study

A randomized, controlled study comparing standard conservative therapy to a minimally invasive treatment called percutaneous disc decompression for painful herniated disc revealed that while both treatments help patients in the short run, only disc decompression kept patients pain free up to two years later.

2 Dec 2009

Universal Access and Human Rights: A central theme for World AIDS Day 2009

More than 33.4 million people are living with HIV/AIDS in the world today with 2.7 million new infections occurring each year. FHSSA reports, Sub-Saharan Africa is unequally impacted by HIV/AIDS, with 71% of new infections each year.

2 Dec 2009

Scientist honored with 2010 University of Louisville Grawemeyer Award for Psychology

A scientist who broadened the understanding of how we experience pain -- and ways we can control and relieve it -- has won the 2010 University of Louisville Grawemeyer Award for Psychology.

2 Dec 2009

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Dyax Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.

2 Dec 2009

ASH to host annual High School Student Symposium at New Orleans Marriott

The American Society of Hematology (ASH) will host its annual High School Student Symposium at the New Orleans Marriott on Thursday, December 3, at 8:00 a.m. CST.

1 Dec 2009

Missouri scientists discover aspirin and Tylenol can inhibit vaccine efficacy

With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines.

1 Dec 2009

Music therapy can reduce pain and anxiety in hospice pateints

Add guitars and other musical instruments to the tools caregivers can use to help patients in hospice care. That's what University of Alabama senior Sarah Pitts found when she brought her music therapy skills to patients in Hospice of West Alabama.

1 Dec 2009

Masimo Rainbow SET Acoustic Monitoring receives FDA clearance

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced FDA clearance of its latest innovation -- Masimo Rainbow SET Acoustic Monitoring(TM)( -- )providing noninvasive and continuous respiration rate (RRa(TM)) that is accurate, easy-to-use, and enhances patient compliance.

1 Dec 2009

Versa Card is now Spine Pain Management

Spine Pain Management, Inc. has officially changed its name from "Versa Card, Inc." to "Spine Pain Management, Inc." and has changed its trading symbol from "IGLB" to "SPIN." The name change was effected legally with the Delaware Secretary of State on November 12, 2009 and was effected in the market on November 27, 2009.

1 Dec 2009

Clinical trail shows PAD patients also experience asymptomatic heart disease

Results of a randomized, controlled clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) reveal that one in five patients with narrowing or blockage in arteries that supply blood to the legs and other parts of the body also have significant but silent coronary artery disease.

1 Dec 2009

Childhood obesity can lead to spinal abnormalities

Being overweight as a child could lead to early degeneration in the spine, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

Rebecca Gomez develops anuleaf AD to relieve hemorrhoid sufferers of their symptoms

Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage.

1 Dec 2009

QRxPharma commences Phase 3 pivotal trial of MoxDuo IR

QRxPharma Limited announced today, as part of its Phase 3 program, the initiation of a registration (also called pivotal) trial (Study 008) comparing efficacy and safety profiles of MoxDuo(TM)IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery. The Company expects to complete dosing by close of Q2 2010.

30 Nov 2009